Details for New Drug Application (NDA): 211087
✉ Email this page to a colleague
The generic ingredient in POTASSIUM CHLORIDE 40MEQ is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.
Summary for 211087
Tradename: | POTASSIUM CHLORIDE 40MEQ |
Applicant: | Fresenius Kabi Usa |
Ingredient: | potassium chloride |
Patents: | 0 |
Pharmacology for NDA: 211087
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 211087
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POTASSIUM CHLORIDE 10MEQ | potassium chloride | INJECTABLE;INJECTION | 211087 | ANDA | Fresenius Kabi USA, LLC | 65219-004 | 65219-004-01 | 60 BAG in 1 CARTON (65219-004-01) / 50 mL in 1 BAG (65219-004-00) |
POTASSIUM CHLORIDE 10MEQ | potassium chloride | INJECTABLE;INJECTION | 211087 | ANDA | Fresenius Kabi USA, LLC | 65219-006 | 65219-006-01 | 50 BAG in 1 CARTON (65219-006-01) / 100 mL in 1 BAG (65219-006-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 14.9MG/ML | ||||
Approval Date: | Sep 9, 2020 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 746MG/100ML | ||||
Approval Date: | Sep 9, 2020 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 29.8MG/ML | ||||
Approval Date: | Sep 9, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription